Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Immunotherapy × durvalumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 41 Lung Neoplasms 19 Carcinoma, Hepatocellular 15 Breast Neoplasms 14 Small Cell Lung Carcinoma 12 Urinary Bladder Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Liver Neoplasms 7 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 5 Neoplasm Metastasis 5 Cholangiocarcinoma 5 Carcinoma 5 Biliary Tract Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Melanoma 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Prostatic Neoplasms 3 Neoplasms by Site 3 Gallbladder Neoplasms 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Turcot syndrome 2 Thyroid Neoplasms 2

Interventions

tremelimumab 1 olaparib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04169841 2024-02-13

GUIDE2REPAIR

Centre Georges Francois Leclerc

Phase 2 Active not recruiting

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡